ARCUTIS BIOTHERAPEUTICS INC

Ticker: ARQT CUSIP: 03969K108 Class: Common Stock

J. Goldman & Co LP's Holding History (CIK: 0001412741)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 353,644 Value ($000) $6,666 Avg Close $15.77 Range $13.06 - $19.36

Q2 2025

Shares 860,260 Value ($000) $12,061 Avg Close $14.02 Range $11.86 - $17.43

Q1 2025

Shares 180,521 Value ($000) $2,823 Avg Close $14.09 Range $11.13 - $17.75

Q4 2024

Shares 612,644 Value ($000) $8,534 Avg Close $10.96 Range $8.03 - $15.79

Q3 2024

Shares 1,492,217 Value ($000) $13,878 Avg Close $9.87 Range $7.86 - $11.33

Q2 2024

Shares 1,311,549 Value ($000) $12,197 Avg Close $9.04 Range $6.99 - $13.17

Q1 2024

Shares 1,435,318 Value ($000) $14,224 Avg Close $7.46 Range $3.07 - $12.35

Q4 2023

Shares 167,733 Value ($000) $542 Avg Close $2.72 Range $1.76 - $5.26

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	353,644	$6,666	$15.77	$13.06 - $19.36
Q2 2025	860,260	$12,061	$14.02	$11.86 - $17.43
Q1 2025	180,521	$2,823	$14.09	$11.13 - $17.75
Q4 2024	612,644	$8,534	$10.96	$8.03 - $15.79
Q3 2024	1,492,217	$13,878	$9.87	$7.86 - $11.33
Q2 2024	1,311,549	$12,197	$9.04	$6.99 - $13.17
Q1 2024	1,435,318	$14,224	$7.46	$3.07 - $12.35
Q4 2023	167,733	$542	$2.72	$1.76 - $5.26